| Catalog | name | Description | price |
|---|---|---|---|
| R-S-9023 | Biotinamidohexanoic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt | Biotinamidohexanoic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt,CAS#:127062-22-0 | price> |
| R-C-436 | Dapagliflozin(BMS5121458) | Dapagliflozin(BMS512148)is a selective,orally active inhibitor of the renal sodium-glucose co-transporter type 2(SGLT2)is in development for the treatment of type 2 diabetes mellitus.Dapagliflozin inhibits subtype 2 of SGLT2 which are responsible for at least 90% of the glucose reabsorption in the kidney.Blocking this transporter mechanism causes blood glucose to be eliminated through the urine.In clinical trials,dapagliflozin lowered HbA1c by 0.90 percentage points when added to metformin. | price> |
| R-C-448 | NPS-2143 | Nps-2143(sb-262470a),an oral active calcium solubilizer,is a selective calcium sensitive receptor(CaSR)antagonist.Nps-2143(sb-262470a)increased the cytosolic Ca2+concentration (IC50=43 nm) by activating Ca2+receptor in HEK 293 cells expressing human Ca2 + receptor. | price> |
| R-C-469 | GSK1292263 CAS:1032823-75-8 | GSK-1292263 is an orally available GPR119 agonist with pEC50s of 6.9 and 6.7 for human and rat GPR119,respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus(T2DM).GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. | price> |
| R-C-504 | FUB359 cas:184025-18-1 | Ciproxifan maleate (FUB 359 maleate) is a potent,selective,orally bioavailable and competitive antagonist of histamine H3-receptor,with an IC50 of 9.2 nM. Ciproxifan maleate displays low apparent affinity at other receptor subtypes. Ciproxifan maleate can be used for the research of aging disorders and Alzheimer disease. | price> |
| R-C-509 | Tasosartan cas:145733-36-4 | Tasosartan is a long-acting angiotensin II(AngII)receptor antagonist. | price> |
| R-C-516 | ARN-509 cas:956104-40-8 | ARN-509 is an androgen receptor antagonist with potential antineoplastic activity.ARN-509 binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus.This prevents binding to and transcription of AR-responsive genes. | price> |
| R-C-525 | Nedocromil cas:69049-73-6 | Nedocromil suppresses the action or formation of multiple mediators,including histamine,leukotriene C4 (LTC4),and prostaglandin D2(PGD2). | price> |
| R-C-544 | WZ 811 CAS 55778-02-4 | WZ811 is an orally active, highly potent competitive antagonist of CXCR4.WZ811 efficiently inhibits CXCR4/SDF-1(or CXCL12)-mediated modulation of cAMP levels (EC50=1.2 nM) and SDF-1 induced Matrigel invasion in cells (EC50=5.2 nM). | price> |
| R-C-568 | CP-945598 cas:686347-12-6 | Otenabant(CP-945598) HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM,exhibits 10,000-fold greater selectivity against human CB2 receptor. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


